XTX Topco Ltd

Position in EXEL — Exelixis, Inc.

CIK 1828301 LONDON, X0

Position in EXEL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,764,973

+$857,328 QoQ

Shares Held

134,413

+20.0% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

XTX Topco Ltd holds $285,821,171 across 374 Biotechnology names. EXEL ranks #4 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	255,431	$7,075,438
2	VRTX	Vertex Pharmaceuticals Inc / Ma	15,632	$6,980,313
3	IONS	Ionis Pharmaceuticals Inc	80,519	$6,046,171
4	EXEL	Exelixis, Inc. This page	134,413	$5,764,973
5	NUVL	Nuvalent, Inc.	53,354	$5,466,117
6	AGIO	Agios Pharmaceuticals, Inc.	160,880	$5,442,570
7	BMRN	Biomarin Pharmaceutical Inc	93,609	$5,287,972
8	RYTM	Rhythm Pharmaceuticals, Inc.	59,502	$5,174,888

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,764,973	134,413	+20.0%	Shares	Defined	2026-05-15
2025-12-31	$4,907,645	111,970	+289.4%	Shares	Defined	2026-02-17
2025-06-30	$1,267,476	28,754	-30.0%	Shares	Defined	2025-08-12
2025-03-31	$1,516,156	41,066	+32.7%	Shares	Defined	2025-05-08
2024-12-31	$1,030,601	30,949	+125.1%	Shares	Defined	2025-02-13
2024-06-30	$308,917	13,748	+15.7%	Shares	Defined	2024-08-12
2023-12-31	$285,049	11,882	-32.6%	Shares	Defined	2024-02-13
2023-09-30	$385,215	17,630	-26.5%	Shares	Defined	2023-11-13
2023-06-30	$458,181	23,976	+8.4%	Shares	Defined	2023-08-14
2022-12-31	$354,933	22,128	-1.5%	Shares	Defined	2023-02-14
2022-09-30	$352,282	22,467	+90.0%	Shares	Defined	2022-11-14
2021-12-31	$216,124	11,823	-35.9%	Shares	Defined	2022-02-11
2021-03-31	$416,582	18,441	—	Shares	Defined	2021-05-14
No filing history on record for this holder in this stock.